In last trading session, Gilead Sciences, Inc (NASDAQ:GILD) saw 6.05 million shares changing hands with its beta currently measuring 0.31. Company’s recent per share price level of $105.93 trading at -$1.27 or -1.18% at ring of the bell on the day assigns it a market valuation of $131.77B. That closing price of GILD’s stock is at a discount of -13.24% from its 52-week high price of $119.96 and is indicating a premium of 37.69% from its 52-week low price of $66.01.
For Gilead Sciences, Inc (GILD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.87. Splitting up the data highlights that, out of 17 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Gilead Sciences, Inc (NASDAQ:GILD) trade information
Upright in the red during last session for losing -1.18%, in the last five days GILD remained trading in the red while hitting it’s week-highest on Wednesday, 06/18/25 when the stock touched $105.93 price level, adding 5.23% to its value on the day. Gilead Sciences, Inc’s shares saw a change of 49.89% in year-to-date performance and have moved -1.92% in past 5-day. Gilead Sciences, Inc (NASDAQ:GILD) showed a performance of -1.34% in past 30-days.
Wall Street analysts have assigned a consensus price target of 126 to the stock, which implies a rise of 15.93% to its current value. Analysts have been projecting 83 as a low price target for the stock while placing it at a high target of 135. It follows that stock’s current price would jump 21.65% in reaching the projected high whereas dropping to the targeted low would mean a gain of 21.65% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -38.13% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 72.50% while estimates for its earnings growth in next 5 years are of 26.05%.
Gilead Sciences, Inc (NASDAQ:GILD)’s Major holders
BLACKROCK INC. is the top institutional holder at GILD for having 120.63 million shares of worth $8.28 billion. And as of 2024-06-30, it was holding 9.6738 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 115.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2431 of outstanding shares, having a total worth of $7.91 billion.
